Millard R - Search Results

1

Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity.

Millard R, Tuttle J, Moore K, Susset J, Clarke B, Dwyer P, Davis BE. Millard R, et al. J Urol. 1999 May;161(5):1551-5. J Urol. 1999. PMID: 10210394 Clinical Trial.

2

Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.

Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC; Duloxetine UI Study Group. Millard RJ, et al. BJU Int. 2004 Feb;93(3):311-8. doi: 10.1111/j.1464-410x.2004.04607.x. BJU Int. 2004. PMID: 14764128 Clinical Trial.

3

Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder.

Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH. Burcher E, et al. Among authors: millard rj. J Urol. 2000 Jan;163(1):331-7. J Urol. 2000. PMID: 10604385

4

Molecular characterization of M2 and M3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity.

Mansfield KJ, Liu L, Moore KH, Vaux KJ, Millard RJ, Burcher E. Mansfield KJ, et al. BJU Int. 2007 Jun;99(6):1433-8. doi: 10.1111/j.1464-410X.2007.06866.x. BJU Int. 2007. PMID: 17428242

5

Treatment of overactive bladder: long-term tolerability and efficacy of tolterodine.

Appell RA, Abrams P, Drutz HP, Van Kerrebroeck PE, Millard R, Wein A. Appell RA, et al. Among authors: millard r. World J Urol. 2001 Apr;19(2):141-7. doi: 10.1007/pl00007094. World J Urol. 2001. PMID: 11374317 Clinical Trial.

6

Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing.

Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Mansfield KJ, et al. Br J Pharmacol. 2005 Apr;144(8):1089-99. doi: 10.1038/sj.bjp.0706147. Br J Pharmacol. 2005. PMID: 15723094 Free PMC article.

7

Urinary incontinence: the Cinderella subject.

Millard RJ, Moore KH. Millard RJ, et al. Med J Aust. 1996 Aug 5;165(3):124-5. doi: 10.5694/j.1326-5377.1996.tb124880.x. Med J Aust. 1996. PMID: 8709870 No abstract available.

8

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.

Hill S, Elhilali M, Millard RJ, Dwyer PL, Lheritier K, Kawakami FT, Steel M. Hill S, et al. Curr Med Res Opin. 2007 Nov;23(11):2697-704. doi: 10.1185/030079907x233160. Curr Med Res Opin. 2007. PMID: 17892634 Clinical Trial.

9

Clinical efficacy of tolterodine with or without a simplified pelvic floor exercise regimen.

Millard RJ; Asia Pacific Tolterodine Study Group. Millard RJ, et al. Neurourol Urodyn. 2004;23(1):48-53. doi: 10.1002/nau.10167. Neurourol Urodyn. 2004. PMID: 14694457 Clinical Trial.

10

Chua WC, Liu L, Mansfield KJ, Vaux KJ, Moore KH, Millard RJ, Burcher E. Chua WC, et al. Exp Gerontol. 2007 Jul;42(7):686-92. doi: 10.1016/j.exger.2007.02.003. Epub 2007 Feb 20. Exp Gerontol. 2007. PMID: 17399929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters